Federal Register: May 5, 2000 (Volume 65, Number 88)
DOCID: FR Doc 00-11204
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
NOTICE: NOTICES
ACTION: Meetings:
SUBJECT CATEGORY:
National Heart, Lung, and Blood Institute; Notice of Meeting
DOCUMENT SUMMARY:
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Sickle Cell Disease Advisory Committee.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: Sickle Cell Disease Advisory Committee.
Date: June 5, 2000.
Time: 9 a.m. to 5 p.m.
Agenda: Discussion of program policies and issues.
Place: National Institutes of Health, Two Rockledge Center, Suite 9104, 6701 Rockledge Drive, Bethesda, MD 20892.
Contact Person: Charles M. Peterson, MD, Director, Blood
Diseases Program, Division of Blood Diseases and Resources, National
Heart, Lung, and Blood Institute, NIH, Two Rockledge Center, Room
10158, MSC 7950, 6701 Rockledge Drive, Bethesda, MD 20892, 301/435 0050.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Disease and Resources Research, National Institutes of Health, HHS)
Dated: April 26, 2000.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 0011204 Filed 5400; 8:45 am]
BILLING CODE 414001M
SUMMARY:
National Heart, Lung, and Blood Institute,
DOCUMENT BODY 2:
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Sickle Cell Disease Advisory Committee.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: Sickle Cell Disease Advisory Committee.
Date: June 5, 2000.
Time: 9 a.m. to 5 p.m.
Agenda: Discussion of program policies and issues.
Place: National Institutes of Health, Two Rockledge Center, Suite 9104, 6701 Rockledge Drive, Bethesda, MD 20892.
Contact Person: Charles M. Peterson, MD, Director, Blood
Diseases Program, Division of Blood Diseases and Resources, National
Heart, Lung, and Blood Institute, NIH, Two Rockledge Center, Room
10158, MSC 7950, 6701 Rockledge Drive, Bethesda, MD 20892, 301/435 0050.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Disease and Resources Research, National Institutes of Health, HHS)
Dated: April 26, 2000.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 0011204 Filed 5400; 8:45 am]
BILLING CODE 414001M